Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totaling 75,842 shares, an increase of 1,602.8% from the December 31st total of 4,454 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 645,779 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 645,779 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short.
Daiichi Sankyo Trading Down 4.1%
OTCMKTS DSNKY opened at $19.04 on Thursday. The firm has a market capitalization of $36.07 billion and a PE ratio of 17.96. The stock’s 50 day moving average is $21.99 and its 200 day moving average is $23.57. Daiichi Sankyo has a twelve month low of $18.91 and a twelve month high of $29.68. The company has a quick ratio of 1.60, a current ratio of 2.31 and a debt-to-equity ratio of 0.06.
Wall Street Analysts Forecast Growth
Separately, Zacks Research downgraded Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 19th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy”.
About Daiichi Sankyo
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Featured Stories
- Five stocks we like better than Daiichi Sankyo
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
